Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: Lung Cancer. 2020 Apr 30;145:132–139. doi: 10.1016/j.lungcan.2020.03.023

Table 2:

Patient Demographics, Disease and Treatment Characteristics by Radiation Pneumonitis Grades

All Patients Grade 2 RP (%) Grade 3–5 RP (%) p-value Non-lethal RP (%) Lethal RP (%) p-value
Extent* 0.003 0.0008
 Median 8.5 8 12 8 15
 Range 3–15 3–12 4–15 3–15 8–15
Distribution <0.0001 0.0003
 Diffuse 11 2 (18%) 9 (82%) 6 (55%) 5 (45%)
 Other 71 58 (82%) 13 (18%) 69 (97%) 2 (3%)
Bilateral Involvement 0.14 0.23
 Yes 48 32 (67%) 16 (33%) 42 (88%) 6 (12%)
 No 34 28 (82%) 6 (18%) 33 (97%) 1 (3%)
All Lobe Involvement 0.11 0.006
 Yes 28 17 (61%) 11 (39%) 22 (79%) 6 (21%)
 No 54 43 (80%) 11 (20%) 53 (98%) 1 (2%)
Out of Field 0.75 0.34
 Yes 67 48 (72%) 19 (28%) 60 (90%) 7 (10%)
 No 15 12 (80%) 3 (20%) 15 (100%) 0
Radiographic Pattern 0.0003 0.0002
 AIP/ARDS patterns 10 2 (20.0%) 8 (80.0%) 5 (50.0%) 5 (50.0%)
 Other patterns 72 58 (80.6%) 14 (19.4%) 70 (97.2%) 2 (2.8%)

RP – radiation pneumonitis, AIP/ARDS – acute interstitial pneumonia/acute respiratory distress syndrome

*

Extent was obtained for each patient as the sum of the scores in the upper, and middle, and lower lungs.